MAM
SYRS

Martingale Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Martingale Asset Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,722
Closed -$329K – 1061
2020
Q3 		$329K Sell
3,722
-5,490
-60% -$485K ﹤0.01% 894
2020
Q2 		$982K Buy
+9,212
New +$982K 0.01% 732